Clinical Trials Browser

Phase 2 × NIH × ulipristal × Clear all

NCT00290251 2024-07-15

Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914

Phase 2 Completed

72 enrolled 7 charts

Leiomyoma

NCT00044876 2019-12-17

Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist

Phase 2 Completed

Leiomyoma, Myofibroma